Stocktoria
HALOZYME THERAPEUTICS, INC. HALO
HALOZYME THERAPEUTICS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 17,619,937 | $922.6M | 14.22% |
| D. E. Shaw & Co., Inc. | 1,899,408 | $122.8M | 1.53% |
| TWO SIGMA INVESTMENTS, LP | 1,584,961 | $102.4M | 1.28% |
| AQR CAPITAL MANAGEMENT LLC | 1,016,429 | $64.8M | 0.82% |
| RENAISSANCE TECHNOLOGIES LLC | 731,811 | $47.3M | 0.59% |
| Bridgewater Associates, LP | 511,429 | $33.1M | 0.41% |
| MILLENNIUM MANAGEMENT LLC | 471,284 | $30.5M | 0.38% |
| CITADEL ADVISORS LLC | 281,851 | $18.2M | 0.23% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.